North America Uterine Cancer Market Size & Outlook, 2025-2033


North America Uterine Cancer Market Insights

  • As per Reed Intelligence insights, North America’s Uterine Cancer Market was valued at USD 1881.13 Million in 2024 and is anticipated to expand to USD 2842.17 Million by 2033.
  • From 2026 to 2033, the market is anticipated to expand at a CAGR of 4.73%.
  • Within By Type, Endometrial Adenocarcinoma accounted for the largest market size in 2024.
  • During the forecast period, Uterine Sarcoma is anticipated to remain the highest-growth segment within the By Type category.

Other Key Findings


  • North America represented 30.05% of the global Uterine Cancer Market size in 2024.
  • By 2033, United States is estimated to hold the largest position in the global market in terms of size.
  • United States is estimated to remain the fastest-growing market in North America, advancing to USD 2099.76 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 1881.13 Million
Market Size In 2033 USD 2842.17 Million
Largest segment Endometrial Adenocarcinoma
Units Revenue in USD Million
CAGR 4.73% (2025-2033)
Segmnetation Covered
North America
  1. United States
  2. Canada
By Type
  1. Endometrial Adenocarcinoma
  2. Adenosquamous Carcinoma
  3. Papillary Serous Carcinoma
  4. Uterine Sarcoma
By Treatment
  1. Diagnosis
  2. Therapeutic Treatment
  3. Surgery
By End-Users
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends